Clinical Trials Logo

Filter by:
NCT ID: NCT00189670 Completed - Clinical trials for Node Positive Breast Cancer

Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer

Start date: n/a
Phase: Phase 2
Study type: Interventional

To screen a dose-dense arm to be used in a future large scale phase III trial. Primary endpoint is safety; secondary endpoints are disease free survival and overall survival. A total of 100 patients were included.

NCT ID: NCT00189696 Completed - Clinical trials for Irritable Bowel Syndrome

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Start date: n/a
Phase: Phase 3
Study type: Interventional

This study will examine the efficacy, safety and tolerability of oral dose of YM060, 5-HT3 receptor antagonist, in patients with d-IBS.

NCT ID: NCT00189722 Completed - Bronchial Asthma Clinical Trials

Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

Start date: n/a
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.

NCT ID: NCT00189761 Completed - Clinical trials for Graft Versus Host Disease

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Start date: n/a
Phase: Phase 2
Study type: Interventional

A study to assess efficacy, safety and pharmacokinetics of a tacrolimus new oral formulation (MR4) in de novo bone marrow transplant recipients

NCT ID: NCT00189774 Completed - Clinical trials for Type 2 Diabetes Mellitus

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment.

NCT ID: NCT00189787 Completed - Bronchial Asthma Clinical Trials

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

Start date: n/a
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.

NCT ID: NCT00189800 Completed - Overactive Bladder Clinical Trials

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to ascertain the clinical results of solifenacin succinate of PIII study conducted in the original country using Korean patients with an overactive bladder.

NCT ID: NCT00198302 Completed - Clinical trials for Staphylococcus Aureus Bacteremia

Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)

Start date: n/a
Phase: Phase 2
Study type: Interventional

Hospitalized patients at least 18 years of age, with Staphylococcus aureus bacteremia (SAB) will be enrolled into the study and receive one dose of Aurexis® intravenously on Study Day 1, and will be followed until Study Day 57. Aurexis is a humanized monoclonal antibody that is designed to combat Staphylococcus aureus. The purpose of this study is to assess the safety and pharmacokinetics of standard antibiotic therapy, plus Aurexis or Placebo for treatment of (SAB). Additionally, certain tests and measurements will be conducted to preliminarily determine if Aurexis demonstrates any benefit to these patients.

NCT ID: NCT00198640 Completed - Infection Clinical Trials

AMR of Streptococcus Pneumoniae Carriage Strains

Start date: n/a
Phase: N/A
Study type: Interventional

This study looks at the usage of human antibiotics for treatment of animals in Bangladesh.

NCT ID: NCT00199173 Completed - Colorectal Neoplasm Clinical Trials

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Start date: n/a
Phase: Phase 3
Study type: Interventional

This is a Phase III trial comparing hepatic intra-arterial injection of Yttrium-90 microspheres (selective internal radiation [SIR] spheres) versus infusional intravenous (IV) 5FU in colorectal cancer metastatic to the liver only and refractory to standard IV chemotherapy.